Literature DB >> 1374603

Fetal haemoglobin and early manifestations of homozygous sickle cell disease.

K Bailey1, J S Morris, P Thomas, G R Serjeant.   

Abstract

The relevance of fetal haemoglobin (HbF) concentration to the development of early clinical manifestations of homozygous sickle (SS) disease has been investigated by examining the time to first occurrence and the proportional hazard of these complications in three groups of the HbF distribution at age 5 years. HbF was significantly related to dactylitis, painful crises, acute chest syndrome, and acute splenic sequestration. The relationship suggested that a critically low HbF concentration increased the risk, little difference in risk occurring between the medium and high HbF groups. The abdominal painful crisis and hypersplenism were not related to HbF concentration suggesting that the degree of sickling may not be important in their genesis. Parental education on acute splenic sequestration should be focused on children with HbF concentrations in the lowest part of the HbF distribution for age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374603      PMCID: PMC1793326          DOI: 10.1136/adc.67.4.517

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

2.  Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia.

Authors:  J F Bertles; P F Milner
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

3.  Irreversibly sickled cells and splenomegaly in sickle-cell anaemia.

Authors:  G R Serjeant
Journal:  Br J Haematol       Date:  1970-11       Impact factor: 6.998

4.  Post-natal decline of fetal haemoglobin in homozygous sickle cell disease: relationship to parenteral Hb F levels.

Authors:  K P Mason; Y Grandison; R J Hayes; B E Serjeant; G R Serjeant; S Vaidya; W G Wood
Journal:  Br J Haematol       Date:  1982-11       Impact factor: 6.998

5.  Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects.

Authors:  R P Perrine; M E Pembrey; P John; S Perrine; F Shoup
Journal:  Ann Intern Med       Date:  1978-01       Impact factor: 25.391

6.  Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae.

Authors:  H C Wallenburg; G A Dekker; J W Makovitz; P Rotmans
Journal:  Lancet       Date:  1986-01-04       Impact factor: 79.321

7.  Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood.

Authors:  M C Stevens; R J Hayes; S Vaidya; G R Serjeant
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

8.  Acute splenic sequestration in homozygous sickle cell disease: natural history and management.

Authors:  A M Emond; R Collis; D Darvill; D R Higgs; G H Maude; G R Serjeant
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

9.  Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease.

Authors:  J M Topley; D W Rogers; M C Stevens; G R Serjeant
Journal:  Arch Dis Child       Date:  1981-10       Impact factor: 3.791

10.  Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?

Authors:  D R Powars; J N Weiss; L S Chan; W A Schroeder
Journal:  Blood       Date:  1984-04       Impact factor: 22.113

View more
  16 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

2.  Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis.

Authors:  C Antwi-Boasiako; E Frimpong; G K Ababio; B Dzudzor; I Ekem; B Gyan; N A Sodzi-Tettey; D A Antwi
Journal:  Ghana Med J       Date:  2015-06

3.  Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease.

Authors:  Carlton Dampier; Beth Ely; Darcy Brodecki; Camille Coleman; Leela Aertker; Jocelyn Andrel Sendecki; Benjamin Leiby; Karen Kesler; Terry Hyslop; Marie Stuart
Journal:  Pediatr Blood Cancer       Date:  2013-09-24       Impact factor: 3.167

Review 4.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

5.  Factors affecting prepubertal growth in homozygous sickle cell disease.

Authors:  A Singhal; J Morris; P Thomas; G Dover; D Higgs; G Serjeant
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

Review 6.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

7.  Appendectomy during pregnancy in sickle cell disease patients.

Authors:  Abdulrahman S Al-Mulhim
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

Review 8.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

9.  Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.

Authors:  Hassana Fathallah; Ali Taher; Ali Bazarbachi; George F Atweh
Journal:  Blood Cells Mol Dis       Date:  2009-04-05       Impact factor: 3.039

10.  Frequency of beta S globin gene haplotypes among sickle cell patients in Nigeria.

Authors:  Abosede Adabale; Samira Batista Lobo Makanjuola; Akinsegun Akinbami; Adedoyin Dosunmu; Alani Akanmu; Farideh A Javid; Louis C Ajonuma
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.